OneAquaHealth Project
0.1.0-ci-build - ci-build 150

OneAquaHealth Project, published by OneAquaHealth Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/oah/ and changes regularly. See the Directory of published versions

Resource Profile: ObservationHealthMeasureOah - Examples

Draft as of 2026-01-27

Examples for the observation-health-measure-oah Profile.

Observation - Benevento % of people with high total cholesterolemia (>=190 mg/dl) (BN1 Female-Age-35-74)
Observation - Benevento % of people with high total cholesterolemia (>=190 mg/dl) (BN1 Male-Age-35-74)
Observation - Benevento % of people with high total cholesterolemia (>=240 mg/dl) (BN1 Female-Age-35-74)
Observation - Benevento % of people with high total cholesterolemia (>=240 mg/dl) (BN1 Male-Age-35-74)
Observation - Benevento % of people affected from CVD (BN1 Female-Age-35-74)
Observation - Benevento % of people affected from CVD (BN1 Male-Age-35-74)
Observation - Benevento % of people with high blood sugar/diabetes (BN1 Female-Age-35-74)
Observation - Benevento % of people with high blood sugar/diabetes (BN1 Male-Age-35-74)
Observation - Benevento % of people under treatment for diabetes (BN1 Female-Age-35-74)
Observation - Benevento % of people under treatment for diabetes (BN1 Male-Age-35-74)
Observation - Benevento % of people with high blood pressure (prevalence) (BN1 Female-Age-35-74)
Observation - Benevento % of people with high blood pressure (prevalence) (BN1 Male-Age-35-74)
Observation - Benevento % of people under treatment for high blood pressure (BN1 Female-Age-35-74)
Observation - Benevento % of people under treatment for high blood pressure (BN1 Male-Age-35-74)
Observation - Benevento % of people under treatment for hypercholesterolemia (BN1 Female-Age-35-74)
Observation - Benevento % of people under treatment for hypercholesterolemia (BN1 Male-Age-35-74)
Observation - Benevento % of people under treatment for hypertension (BN1 Female-Age-35-74)
Observation - Benevento % of people under treatment for hypertension (BN1 Male-Age-35-74)
Observation - Benevento % of people affected from obesity (BN1 Female-Age-35-74)
Observation - Benevento % of people affected from obesity (BN1 Male-Age-35-74)
Observation - Benevento % of people with high total cholesterolemia (>=190 mg/dl) (BN2 Female-Age-35-74)
Observation - Benevento % of people with high total cholesterolemia (>=190 mg/dl) (BN2 Male-Age-35-74)
Observation - Benevento % of people with high total cholesterolemia (>=240 mg/dl) (BN2 Female-Age-35-74)
Observation - Benevento % of people with high total cholesterolemia (>=240 mg/dl) (BN2 Male-Age-35-74)
Observation - Benevento % of people affected from CVD (BN2 Female-Age-35-74)
Observation - Benevento % of people affected from CVD (BN2 Male-Age-35-74)
Observation - Benevento % of people with high blood sugar/diabetes (BN2 Female-Age-35-74)
Observation - Benevento % of people with high blood sugar/diabetes (BN2 Male-Age-35-74)
Observation - Benevento % of people under treatment for diabetes (BN2 Female-Age-35-74)
Observation - Benevento % of people under treatment for diabetes (BN2 Male-Age-35-74)
Observation - Benevento % of people with high blood pressure (prevalence) (BN2 Female-Age-35-74)
Observation - Benevento % of people with high blood pressure (prevalence) (BN2 Male-Age-35-74)
Observation - Benevento % of people under treatment for high blood pressure (BN2 Female-Age-35-74)
Observation - Benevento % of people under treatment for high blood pressure (BN2 Male-Age-35-74)
Observation - Benevento % of people under treatment for hypercholesterolemia (BN2 Female-Age-35-74)
Observation - Benevento % of people under treatment for hypercholesterolemia (BN2 Male-Age-35-74)
Observation - Benevento % of people under treatment for hypertension (BN2 Female-Age-35-74)
Observation - Benevento % of people under treatment for hypertension (BN2 Male-Age-35-74)
Observation - Benevento % of people affected from obesity (BN2 Female-Age-35-74)
Observation - Benevento % of people affected from obesity (BN2 Male-Age-35-74)
Observation - Benevento % of people with high total cholesterolemia (>=190 mg/dl) (BN3 Female-Age-35-74)
Observation - Benevento % of people with high total cholesterolemia (>=190 mg/dl) (BN3 Male-Age-35-74)
Observation - Benevento % of people with high total cholesterolemia (>=240 mg/dl) (BN3 Female-Age-35-74)
Observation - Benevento % of people with high total cholesterolemia (>=240 mg/dl) (BN3 Male-Age-35-74)
Observation - Benevento % of people affected from CVD (BN3 Female-Age-35-74)
Observation - Benevento % of people affected from CVD (BN3 Male-Age-35-74)
Observation - Benevento % of people with high blood sugar/diabetes (BN3 Female-Age-35-74)
Observation - Benevento % of people with high blood sugar/diabetes (BN3 Male-Age-35-74)
Observation - Benevento % of people under treatment for diabetes (BN3 Female-Age-35-74)
Observation - Benevento % of people under treatment for diabetes (BN3 Male-Age-35-74)
Observation - Benevento % of people with high blood pressure (prevalence) (BN3 Female-Age-35-74)
Observation - Benevento % of people with high blood pressure (prevalence) (BN3 Male-Age-35-74)
Observation - Benevento % of people under treatment for high blood pressure (BN3 Female-Age-35-74)
Observation - Benevento % of people under treatment for high blood pressure (BN3 Male-Age-35-74)
Observation - Benevento % of people under treatment for hypercholesterolemia (BN3 Female-Age-35-74)
Observation - Benevento % of people under treatment for hypercholesterolemia (BN3 Male-Age-35-74)
Observation - Benevento % of people under treatment for hypertension (BN3 Female-Age-35-74)
Observation - Benevento % of people under treatment for hypertension (BN3 Male-Age-35-74)
Observation - Benevento % of people affected from obesity (BN3 Female-Age-35-74)
Observation - Benevento % of people affected from obesity (BN3 Male-Age-35-74)
Observation - Oslo % of people with BMI =>30 (Age-18-29)
Observation - Oslo % of people with BMI =>30 (Age-30-39)
Observation - Oslo % of people with BMI =>30 (Age-40-49)
Observation - Oslo % of people with BMI =>30 (Age-50-59)
Observation - Oslo % of people with BMI =>30 (Age-60-69)
Observation - Oslo % of people with BMI =>30 (Age-70-plus)
Observation - Oslo % of people with BMI =>30 (All)
Observation - Oslo % of people with BMI =>30 (Female)
Observation - Oslo % of people with BMI =>30 (Male)
Observation - Oslo % of people with BMI <18,5 (Age-18-29)
Observation - Oslo % of people with BMI <18,5 (Age-30-39)
Observation - Oslo % of people with BMI <18,5 (Age-40-49)
Observation - Oslo % of people with BMI <18,5 (Age-50-59)
Observation - Oslo % of people with BMI <18,5 (Age-60-69)
Observation - Oslo % of people with BMI <18,5 (Age-70-plus)
Observation - Oslo % of people with BMI <18,5 (All)
Observation - Oslo % of people with BMI <18,5 (Female)
Observation - Oslo % of people with BMI <18,5 (Male)
Observation - Oslo % of people with BMI 18,5-24,9 (Age-18-29)
Observation - Oslo % of people with BMI 18,5-24,9 (Age-30-39)
Observation - Oslo % of people with BMI 18,5-24,9 (Age-40-49)
Observation - Oslo % of people with BMI 18,5-24,9 (Age-50-59)
Observation - Oslo % of people with BMI 18,5-24,9 (Age-60-69)
Observation - Oslo % of people with BMI 18,5-24,9 (Age-70-plus)
Observation - Oslo % of people with BMI 18,5-24,9 (All)
Observation - Oslo % of people with BMI 18,5-24,9 (Female)
Observation - Oslo % of people with BMI 18,5-24,9 (Male)
Observation - Oslo % of people with BMI 25-29,9 (Age-18-29)
Observation - Oslo % of people with BMI 25-29,9 (Age-30-39)
Observation - Oslo % of people with BMI 25-29,9 (Age-40-49)
Observation - Oslo % of people with BMI 25-29,9 (Age-50-59)
Observation - Oslo % of people with BMI 25-29,9 (Age-60-69)
Observation - Oslo % of people with BMI 25-29,9 (Age-70-plus)
Observation - Oslo % of people with BMI 25-29,9 (All)
Observation - Oslo % of people with BMI 25-29,9 (Female)
Observation - Oslo % of people with BMI 25-29,9 (Male)
Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Age-18-29)
Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Age-30-39)
Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Age-40-49)
Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Age-50-59)
Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Age-60-69)
Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Age-70-plus)
Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (All)
Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Female)
Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Male)
Observation - Oslo % of people with long-term disease (Age-18-29)
Observation - Oslo % of people with long-term disease (Age-30-39)
Observation - Oslo % of people with long-term disease (Age-40-49)
Observation - Oslo % of people with long-term disease (Age-50-59)
Observation - Oslo % of people with long-term disease (Age-60-69)
Observation - Oslo % of people with long-term disease (Age-70-plus)
Observation - Oslo % of people with long-term disease (All)
Observation - Oslo % of people with long-term disease (Female)
Observation - Oslo % of people with long-term disease (Male)
Observation - Oslo % of people experience with mental health issues (Age-18-29)
Observation - Oslo % of people experience with mental health issues (Age-30-39)
Observation - Oslo % of people experience with mental health issues (Age-40-49)
Observation - Oslo % of people experience with mental health issues (Age-50-59)
Observation - Oslo % of people experience with mental health issues (Age-60-69)
Observation - Oslo % of people experience with mental health issues (Age-70-plus)
Observation - Oslo % of people experience with mental health issues (All)
Observation - Oslo % of people experience with mental health issues (Female)
Observation - Oslo % of people experience with mental health issues (Male)
Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Age-18-29)
Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Age-30-39)
Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Age-40-49)
Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Age-50-59)
Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Age-60-69)
Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Age-70-plus)
Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (All)
Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Female)
Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Male)
Observation - Oslo % of people without long-term disease (Age-18-29)
Observation - Oslo % of people without long-term disease (Age-30-39)
Observation - Oslo % of people without long-term disease (Age-40-49)
Observation - Oslo % of people without long-term disease (Age-50-59)
Observation - Oslo % of people without long-term disease (Age-60-69)
Observation - Oslo % of people without long-term disease (Age-70-plus)
Observation - Oslo % of people without long-term disease (All)
Observation - Oslo % of people without long-term disease (Female)
Observation - Oslo % of people without long-term disease (Male)